Buy GHRP-2 Acetate 5mg Research Peptide OnlineGHRP-2 (Growth Hormone Releasing Peptide-2) acetate is a synthetic hexapeptide (His-D-2-methyl-Trp-Ala-Trp-D-Phe-Lys-NH2) classified as a growth hormone secretagogue. In preclinical research models, this peptide acts as a ghrelin receptor agonist, stimulating growth hormone release through activation of specific hypothalamic signaling pathways in non-human systems.GHRP-2 Acetate Published Research SummaryThe mechanism involves binding to growth hormone secretagogue receptor (GHSR) on somatotroph cells. Activation of GHSR triggers intracellular calcium mobilization and G-protein signaling cascades, culminating in growth hormone granule exocytosis. Bowers et al. (1991) first characterized GHRP-2’s ability to stimulate GH release in animal studies, and subsequent research confirmed the peptide’s potency and selectivity for GHSR over other neuropeptide receptors.Preclinical pharmacology demonstrates that GHRP-2 operates synergistically with endogenous GHRH (growth hormone releasing hormone), producing additive GH secretion responses. Research in animal models documents dose-dependent increases in plasma growth hormone concentrations following GHRP-2 administration. Bowers et al. (2004) demonstrated that GHRP-2 maintains efficacy across repeated dosing protocols in laboratory animals, with consistent GH stimulation observed over extended treatment periods.GHRP-2 Acetate 5mg Product Specifications & StorageGHRP-2 Acetate is available as lyophilized powder in 5mg vials. Reconstitution requires sterile water or bacteriostatic saline, with solutions remaining stable for 24-48 hours at 4°C. The powdered form demonstrates excellent stability when stored at -20°C or below, maintaining biological activity for extended periods. All reconstituted preparations should be protected from freeze-thaw cycles.This product is designated exclusively for preclinical research and in vitro laboratory investigation. It is prohibited for human use, clinical administration, or therapeutic purposes. All research applications must comply with institutional animal care protocols and regulatory guidelines governing peptide research.
